Member Info for Magsy18

Interest payments were postponed until January 2022.

There is nothing to disagree with drlong. I have stated the known facts and then asked given those facts, how does what you are suggesting make sense?

It amazes me that given some really positive things coming up over the next few weeks, that people still feel the need to make up further stuff.

Ok and now answer the question.

How did this transaction help us to ‘massively upscale’ in the near future?

Ok now explain how this transaction helps us to ‘massively upscale’ in the near future?

Oh and thirdly they actually now have £700k less cash in order to perform this upscaling.

Don’t get me wrong, I think the conversion was a good thing but making up things that make no sense at all isn’t helpful.

Firstly, it wasn’t GDR’s decision to convert and secondly this would have had no impact on their current cash balance until at least January 2022. Surely this upscaling would be happening way before then?

Interest would have had to start being paid from January 2022. Was just clarifying that in the short term we gained no cash.

After that conversion GDR have less cash available due to payment of interest. They didn’t gain any cash at all.

GHIF didn’t give us any money did they?

Congratulations on insulting multiple posters on here including yourself hillbilly.

I would think things through a little more before posting next time.

You have no idea how much it means to this board to have this show of confidence from yourself.

Sure but NCYT was over £4 when sentiment was at its highest which is the equivalent of over £5 for us. With some momentum and significant orders i wouldn’t completely rule out us hitting near £5 although I doubt it would consolidate at that level.

I don’t think India approval alone would even get us above £2 based on the impact of the CE Mark RNS impact. If it also contained confirmation of significant sales then who knows!

I think India approval is what we will get this week. FDA approval the following week. I don’t expect any sales related news this week but would be a lovely surprise if it did come.

The fact that you target me consistently says otherwise.

As always, you are only capable of insults. Hopefully someone genuinely helpful like technik can clarify which USPs communicated in the presentation are still applicable.

Ah you don’t then. Thanks anyway.

Maybe you know flyingmachine? What are the remaining USP's that the GDR test has over NCYT?

RollingInit seems clued up on our USP's compared to the new NCYT test. I am fine with him attacking me but in addition it would be useful for the board is for him to share his knowledge with the board.

As always, unable to make a point without resorting to insults.

I never stated there were no USP's, please ensure that you read posts thoroughly before jumping to inaccurate conclusions.

Are you confirming that the new NCYT test still can't be stored/shipped at ambient temperatures? And also that it still doesn't have human RNA control?

Can someone explain to me how it can be possible for several days in a row to have more buys than sells?